title: Treatment of recurrent or progressive malignant glioma with a recombinant adenovirus expressing human interferon-beta (H5.010CMVhIFN-beta): a phase I trial.
authors.affiliation: University of Pennsylvania Cancer Center, Philadelphia 19104, USA.
authors.forename: S L
authors.initials: SL
authors.lastname: Eck
authors.forename: J B
authors.initials: JB
authors.lastname: Alavi
authors.forename: K
authors.initials: K
authors.lastname: Judy
authors.forename: P
authors.initials: P
authors.lastname: Phillips
authors.forename: A
authors.initials: A
authors.lastname: Alavi
authors.forename: D
authors.initials: D
authors.lastname: Hackney
authors.forename: P
authors.initials: P
authors.lastname: Cross
authors.forename: J
authors.initials: J
authors.lastname: Hughes
authors.forename: G
authors.initials: G
authors.lastname: Gao
authors.forename: J M
authors.initials: JM
authors.lastname: Wilson
authors.forename: K
authors.initials: K
authors.lastname: Propert
mesh_terms: D000256:Adenoviridae / Q000235:genetics* / Q000378:metabolism; D000293:Adolescent; D000328:Adult; D000818:Animals; D001932:Brain Neoplasms / Q000378:metabolism / Q000401:mortality / Q000628:therapy* / Q000821:virology; D015870:Gene Expression; D015316:Genetic Therapy; D005910:Glioma / Q000378:metabolism / Q000401:mortality / Q000628:therapy* / Q000821:virology; D006801:Humans; D016899:Interferon-beta / Q000096:biosynthesis*; D008253:Macaca mulatta / Q000235:genetics / Q000821:virology; D008279:Magnetic Resonance Imaging; D051379:Mice; D008810:Mice, Inbred C57BL; D012008:Recurrence; D018570:Risk Assessment; D012449:Safety; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D016899:Interferon-beta